StockNews.com upgraded shares of Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) from a hold rating to a buy rating in a research note published on Monday. A number of other equities research analysts also recently issued reports on the company. Barclays cut their price target on Amneal Pharmaceuticals from $7.00 to $4.00 and set an overweight […]
500.com reiterated their maintains rating on shares of Amneal Pharmaceuticals (NYSE:AMRX – Get Rating) in a research note released on Monday, Benzinga reports. A number of other equities analysts also recently commented on the stock. StockNews.com assumed coverage on shares of Amneal Pharmaceuticals in a research note on Friday, March 17th. They issued a hold […]
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday. Amneal Pharmaceuticals Stock Performance AMRX traded up $0.10 during trading on Monday, hitting $2.02. 751,600 shares of the stock traded hands, compared to its average volume […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating)’s stock price gapped up prior to trading on Monday following a better than expected earnings announcement. The stock had previously closed at $1.92, but opened at $2.00. Amneal Pharmaceuticals shares last traded at $1.94, with a volume of 81,318 shares changing hands. The company reported $0.10 earnings per […]
Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month target […]